Picture of Orgenesis logo

ORGS Orgenesis Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Orgenesis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line0.579-18.1-12.2-64.9-49
Depreciation
Deferred Taxes
Non-Cash Items-76.84.735.2511.928.2
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-1.9-15.4-19.936.61.67
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Net Change in Other Assets & Liabilities
Cash from Operating Activities-78-26.9-24.9-14.8-17.1
Capital Expenditures-1.52-7.87-12.4-2.1-0.263
Purchase of Fixed Assets
Other Investing Cash Flow Items107-4.52-1.72-1.610.628
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities106-12.4-14.1-3.710.365
Financing Cash Flow Items20.657.49
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities5.88-0.10639.613.616
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash33.5-39.60.395-4.89-0.792